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Summary
Despite the fact that cataracts constitute the leading
cause of blindness worldwide, the mechanisms of lens
opacification remain unclear. We recently mapped the
aculeiform cataract to the g-crystallin locus (CRYG) on
chromosome 2q33-35, and mutational analysis of the
CRYG-genes cluster identified the aculeiform-cataract
mutation in exon 2 of g-crystallin D (CRYGD). This
mutation occurred in a highly conserved amino acid and
could be associated with an impaired folding of CRYGD.
During our study, we observed that the previously re-
ported Coppock-like–cataract mutation, the first human
cataract mutation, in the pseudogene CRYGE repre-
sented a polymorphism seen in 23% of our control pop-
ulation. Further analysis of the original Coppock-
like–cataract family identified a missense mutation in a
highly conserved segment of exon 2 of CRYGC. These
mutations were not seen in a large control population.
There is no direct evidence, to date, that up-regulation
of a pseudogene causes cataracts. To our knowledge,
these findings are the first evidence of an involvement
of CRYGC and support the role of CRYGD in human
cataract formation.
Introduction
The genetic approach toward a better understanding of
cataract formation has led to the identification of 13
cataract-gene loci and the characterization of seven genes
(Brakenhoff et al. 1994; Cartier et al. 1994; Litt et al.
1997, 1998; Hejtmancik 1998; Kannabiran et al. 1998;
Shiels et al. 1998; Mackay et al. 1999; Stephan et al.
1999). The g-crystallin–genes cluster constitutes a family
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of seven genes encoding major structural proteins of the
lens (Papaconstantinou 1967; Piatigorsky 1981, 1984).
Of these, the g-crystallin genes (CRYG) represent an
interesting group of candidate genes for aculeiform cat-
aract (MIM 115700), because of (1) their location in
the disease-gene interval that we have previously
mapped on chromosome 2q33-35 (He´on et al. 1998),
(2) their role in maintenance of lens transparency and
development, and (3) their association with cataract for-
mation in mice and humans (Cartier et al. 1994; Hejt-
mancik 1998). Specifically, mutations in the CRYGgenes
(CRYGA, -B, and -E) have been associated with various
murine cataract models (Cartier et al. 1992; Santhiya et
al. 1995; Klopp et al. 1998). In humans, a group of
sequence changes in the promoter region of CRYGE has
been associated with the Coppock-like–cataract phe-
notype (Brakenhoff et al. 1994) (see table 1). Unlike the
situation in the mouse, the human gE is a pseudogene
by virtue of an in-frame stop codon in exon 2. However,
these sequence changes have been referred to as the
“CCL mutation,” since they were found to be associated
with a 10-fold increase in the expression of gE. This is
the first human cataract mutation that has been iden-
tified, but it also is the first suggestion that the up-reg-
ulation of a pseudogene could be disease causing.
Coppock-like cataract (MIM 116200 and MIM
123660) and aculeiform cataract are distinct clinical en-
tities, in terms of type of lens opacity and their respective
natural histories (fig. 1) (Nettleship and Ogilvie 1906;
Vogt 1922). They both have an autosomal dominant
mode of transmission, but the aculeiform-cataract phe-
notype is characterized by needlelike lens opacification
involving the superficial layer of the fetal nucleus and
perhaps the embryonic nucleus, whereas Coppock-like
cataract refers to a dustlike opacity of the fetal nucleus
with frequent involvement of the zonular lens. A third
phenotype, progressive polymorphic cataract (MIM
601286), also has been mapped to the 2q33-35 locus
(Rogaev et al. 1996). This entity also is clinically distinct
from Coppock-like cataract and aculeiform cataract,
and its genetic defect remains unknown. In an attempt
to identify the aculeiform-cataract–gene defect, a mu-
tational analysis of CRYG genes was performed in three
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Table 1
Mutation Analysis of the CRYGE-Promoter Region in Controls
ETHNIC GROUP/
HAPLOTYPE
NO. OF CONTROLS WITH
NO. OF
ALLELESHaplotype 1a Haplotype 2b Haplotype 3c Haplotype 4d
Swiss 23 17 7 1 48
Western European 20 14 12 0 46
Eastern European 3 5 2 0 10
Afro-Carribean 3 1 4 0 8
East Indian 2 6 0 0 8
Chinese 2 0 4 0 6
Total 53 (42.1%) 43 (34.1%) 29 (23%) 1 (.8%) 126e
a tataTa/cCg.
b tataCa/cCg.
c tataTa/cTg (proposed Coppock-like–cataract mutation, 5′ to exon 1 [Brakenhoff et al. 1994]).
d tataCa/cTg.
e An additional 9 control individuals were sequenced and found to be double heterozygotes.
Figure 1 Clinical example of an aculeiform cataract (left) and a Coppock-like cataract (right), shown by transillumination slit-lamp
photography.
unrelated affected families whose defect previously had
been mapped to the 2q33-35 region (He´on et al. 1998).
Subjects and Methods
Patients and Controls
This study was approved by the Ethics Committee of
the Faculty of Medicine of the University of Lausanne.
Genomic DNA was isolated from peripheral blood by
means of methods described elsewhere (Miller et al.
1988).
Direct Sequencing of CRYGB, -C, -D, and -E
Individuals affected with aculeiform cataract, as well
as unaffected family members, of previously described
pedigrees (He´on et al. 1998) were screened formutations
in CRYGB, -C, -D, and -E, by direct cycle sequencing
(Mitchell and Warshawsky 1998). Gene-specific PCR
primers were designed to amplify the three exons
and flanking intron sequences of crystallin gB, -C, -D,
and -E.
CRYGE.—Because of the high sequence homology of
exon 3 of CRYGE and CRYGF, TaqI restriction-enzyme
digestion of genomic DNA was required prior to am-
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Figure 2 Mutational analysis of CRYGC. a, Sequence chro-
matograms showing the single-base-pair substitution 225ArC of
CRYGC exon 2, found in individuals affected with the Coppock-
like–cataract phenotype. b, HphI restriction-enzyme digestion of
CRYGC exon 2 of a branch of the original Coppock-like–cataract
family. The wild-type fragment contains HphI restriction-enzyme sites
that cut the product into fragments of 344, 82, and 358 bp, which
would show one band on the agarose gel. The 225ArC mutation
disrupts the second restriction-enzyme site, and products of 344 and
440 bp are observed as two bands on a stained agarose gel. Blackened
and unblackened symbols represent affected and unaffected individ-
uals, respectively. Symbols are numbered on the basis of the generation
identifiers in the original publication (Lubsen et al. 1987), with all
individuals numbered from left to right in ascending order.
Table 2
Single-Nucleotide Polymorphisms Observed in
CRYGB, -C, -D, and -E
Crystallin Gene
(Accession Number)
and Nucleotide Variation Amino Acid
gB (M19364):
2104 t/c Noncoding
2437 ccC/ccT Pro
gC (M19364):
18229 a/g Noncoding
gD (K03005):
286 taT/taC Tyr
gE (S72943):
165 c/t Noncoding
179 c/t Noncoding
205 t/g Noncoding
244 c/t Noncoding
406 caG/caA Gln
432 gCg/gTg Ala/Val
455 Gtg/Atg Val/Met
506 g/t Noncoding
164 c/a Noncoding
188 t/c Noncoding
214 g/c Noncoding
318 a/g Noncoding
plification, to ensure primer specificity. Each PCR re-
action contained 100 ng DNA, 200 mM of each dNTP,
5% dimethyl sulfoxide (DMSO), 10 pmol of each primer
(one of which was 5′ biotin labeled), GeneAmp PCR
Buffer II, 1.0–1.5 mM MgCl2, and 1 U AmpliTaq poly-
merase (Applied Biosystems), in 20 ml. Reactions were
performed on an MJ Research PTC-100 or Stratagene
Robocycler for 35 cycles, after an initial denaturing step
(94C for 5 min) and “hot start” addition of AmpliTaq,
variable annealing temperatures, and a final 8-min ex-
tension at 72C. PCR and sequence primers are available
on request.
CRYGD.—Amplification of CRYGD (exons 1 and 2),
required “touchdown” PCR. A 737-bp PCR fragment
covering exons 1 and 2 of CRYGD was amplified by
use of the following primers: forward, 5′-gccgttttacaaa-
cattctc-3′; reverse, 5′-gttattgtgactgatcgctac-3′ (5′ biotin la-
beled). Exon 2 sequencing primers were as follows: for-
ward, 5′-gaaggtgagcccagcctgcg-3′; reverse, 5′-tctaatgtt-
taacttttgcttg-3′. PCR products were purified by use of
Dynabeads M-280 Streptavidin, were resuspended in
20 ml H2O, and were sequenced by use of the Thermo
Sequenase Cycle Sequencing Core Kit (model
US79610; Visible Genetics). The exon 2 sequencing re-
actions, which included 2 ml template, 10% DMSO, and
a nested forward or reverse Cy5.5-labeled primer, were
performed for 35 cycles after an initial denaturing step
(94C for 3 min), variable annealing temperatures, and
a final 8-min extension at 70C. The products were an-
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Figure 3 Mutational analysis of CRYGD. a, Sequence chro-
matograms showing the single-base-pair substitution 411GrA of
CRYGD (exon 2; nucleotides 404–418) found in individuals affected
with the aculeiform-cataract phenotype. b, Mutational analysis (i.e.,
ARMS) of CRYGD exon 2. The ARMS assay shows cosegregation of
the 411GrAmutation with the aculeiform-cataract phenotype in three
Swiss families (families A–C). Selective amplification of a 194-bp PCR
product for the 411GrA mutation is seen in affected individuals only.
The 410-bp fragment amplified with primers for the marker D1S1663
is an internal control for the PCR reaction and is present in all lanes.
alyzed by a MicroGene Blaster automated DNA se-
quencing unit (Visible Genetics). Sequence variants were
analyzed in both directions.
CRYGC.—A 784-bp fragment covering exons 1 and
2 of CRYGC was amplified with the following primers:
forward, 5′-tcaatcatatagacagagcca-3′; and reverse, 5′-
atgtccatctaacccttaggt-3′ (5′ biotin labeled). The sequenc-
ing reactions for exon 2 were similar to those used for
CRYGD—with primers 5′-gagcagaacacaaattaaat-3′ (for-
ward) and 5′-aatgcaaacctccctccctg-3′ (reverse).
Mutation-Detection Assay for CRYGD and CRYGC
CRYGD.—Allele-specific amplification (also known as
“ARMS”) (Newton et al. 1989) was used to screen all
family members and controls, for the proposedmutation
at 411GrA in exon 2 of CRYGD. The forward primer
had a 3′ nucleotide mismatch—5′-gcctccagtacttcctgca-
3′—designed specifically to amplify the mutant allele
and, together with the reverse-PCR primer, amplified a
194-bp mutant allele–specific fragment in affected in-
dividuals. Primers for the STRP marker D1S1663
(409–425 bp) were included in each reaction, as a pos-
itive control for PCR.
The standard PCR reaction contained 25 ng genomic
DNA and 1.75 mM MgCl2 and had an annealing tem-
perature of 59C. Products were electrophoresed on 1%
agarose gel, were stained with ethidium bromide, and
then were visualized by UV transillumination.
CRYGC.—The wild-type DNA contains HphI restric-
tion-enzyme sites that cut the 784-bp PCR product into
fragments of 344, 82, and 358 bp, which are seen as
one band on a stained agarose gel. Themutation disrupts
the second restriction-enzyme site, and products of size
344 and 440 bp are observed as two bands on a stained
agarose gel (fig. 2B). HphI restriction-enzyme digestion
after PCR amplification was used to screen all family
members (nine affected, seven unaffected, and seven
spouses) and controls, for the proposedmutation in exon
2 of CRYGC.
The standard 20-ml PCR reaction contained 50 ng
genomic DNA and 1.5 mM MgCl2, had an annealing
temperature of 59C, and comprised 38 cycles. A 5-ml
portion of amplified product was digested in a 10-ml total
volume for 3 h. Products were electrophoresed on 2%
agarose gel with ethidium bromide staining and then
were visualized by UV transillumination.
Three-Dimensional Protein Prediction
When the tertiary structure of several g-crystallinswas
delineated by x-ray crystallography, it was found to be
highly conserved. Bovine g-B, -D, and -F have
77%–87% identity to human CRYGD and were used
as a reference for homology modeling. Models were
viewed in a Swiss-Pdb Viewer, version 3.1. Homology
modeling was done by SWISS-MODEL, version 2.0.
Results
Mutation Identification of Aculeiform Cataract
Mutation analysis of the g-crystallin–genes cluster
started with CRYGE. A variety of sequence changes
were observed in the promoter region of CRYGE (table
1), none of which appeared to be disease specific. The
sequence changes associated with the Coppock-like–
cataract phenotype (CCL mutation) were seen in one
affected individual and in one unaffected spouse. Fur-
thermore, screening of a control population, character-
ized by individuals with no lens opacification and of
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Table 3
Sequence Homology of CRYGD Amino Acid Residues 48–66 and 170–172
SPECIES CRYSTALLIN
SEQUENCEa
HOMOLOGYb
(%)
5 5 5 6 6
0 5 8 0 5 //
1111
7777
0123
Man gD PNYSGLQYFLRRGDYADHQ // IDFS 100
Bovine gD (IIIB ) ...L.P.........P.Y. // ..IY 87
Rat gD (22) ..FT.C.........P.Y. // ..IY 85
Mouse gD (1) ..FA.C.........P.Y. // M..Y 83
Cat shark gM1 ..FM.M.F.....E.H.M. // T.MC 49
Common carp gM1 NS.M.N.F.....E.H.M. // T.MC 47
gM2 ...M.N...F...E...YM // M.SW 50
gM3 ...M.N.F.M...E...YM // M.LC 50
Teleostean fish gM11 // T.MC 51
Catfish gcry ..FM.M.F.....E.H.M. // T.IC 51
Common frog g1 ...T.H.......E.P.F. // QEMF 57
a From GenBank. Amino acid residue 58 is the site of the aculeiform-cataract mutation.
b Of total protein sequence.
Figure 4 Protein-structure prediction of mutated g-crystallin D: human g-D crystallin prediction by SWISS-MODEL, illustrating the
ARG58HIS mutation (blue) and surrounding region, protein backbone (yellow), and beta sheets (red). Note that amino acid 58 occurs between
two b sheets. The R groups involved with putative hydrogen bonding are displayed; dashed green lines denote strong bonds, and dashed purple
lines denote weak bonds. Left,Wild-type g-D crystallin showing ARG58 and putative hydrogen bond between its R group (blue) and the oxygen
of the carbonyl group of ILE170 near the C terminus. Right, Mutated g-D crystallin showing HIS58 and new putative hydrogen bonds between
its R group (blue) and R group of ASP171 (orange). Also predicted are hydrogen bonding with the backbone of PHE172 (at the nitrogen of
the amide backbone) and weaker hydrogen bonding with the backbone of SER173 (at the nitrogen of the amide backbone).
various ethnic backgrounds (126 informative chromo-
somes), showed that the promoter region ofCRYGEwas
very polymorphic. The CCL mutation was observed in
23% of cases. Direct sequencing of the coding sequence
of CRYGE, CRYGB, and CRYGC failed to document
any disease-causing mutation. The single-nucleotide
polymorphisms identified in these genes are listed in ta-
ble 2.
Direct sequencing of CRYGD showed a GrA tran-
sition at nucleotide position 411 in exon 2, which sub-
stituted the highly conserved amino acid arginine for a
histidine (R58H) (fig. 3A). This sequence change cose-
gregated with the aculeiform-cataract phenotype in the
three families (fig. 3B) and was not observed in 210
control individuals of various ethnic backgrounds, in 44
samples from patients affected with age-related cata-
racts, or in 39 samples from patients with sporadic
congenital cataracts of various subtypes (data not
shown). This amino acid is found in a region that is
highly conserved in the different CRYGs (CRYGA, -B ,
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-C, -D, -E, and -F) (data not shown) and is invariant
through various species (table 3).
Mutation Identification of Coppock-Like Cataract
In an attempt to clarify the role of CRYG in the
Coppock-like cataract, further mutational analysis of the
gene cluster was performed in the original family di-
agnosed with Coppock-like cataract (Lubsen et al.
1987). Sequencing of CRYG genes confirmed the pre-
viously published observations of the sequence changes
in CRYGE and that CRYGD did not carry the disease-
causing mutation. Direct sequencing of CRYGC iden-
tified an ArC transversion in exon 2 (nucleotide position
225 [GenBank K03003]), which changed the amino acid
threonine to a proline (T5P). This change cosegregated
perfectly with the disease phenotype (i.e., it was present
in 9 affected individuals and not in 14 unaffected family
members) (fig. 2); nor was it observed in 215 control
individuals of various ethnic backgrounds, in 39 patients
with congenital cataract, or in 44 patients with age-
related cataracts (data not shown). This mutation lies in
a highly conserved region. The affected amino acid is
invariant in all the g-crystallins of humans, bovine, rat,
and mouse (data not shown).
Discussion
The g-crystallin proteins are tightly folded in two do-
mains with no free loops. Each domain consists of two
Greek-key motifs, each one having a folded hairpin that
provides stability between two b-sheets (Meakin et al.
1985). The mutation R58H induces a change in charge
and is predicted to introduce hydrogen bonds with res-
idues 171, 172, and 173 (fig. 4). These are crystallo-
graphic contact sites (Sergeev et al. 1998), which, when
altered, may impair the proper folding of the protein,
by either increasing its rigidity or altering its stability.
In addition, this mutation is adjacent to an RGD motif
known to play a role in cell adhesion. It is possible that
the R58H mutation destabilizes the contact between
lens-fiber cells, which is critical for the maintenance of
lens transparency (White et al. 1989). Improper folding
of CRYGD, the most abundantly expressed g-crystallin
in the lens, could well cause protein aggregation and
lens opacification. A different mutation in CRYGD re-
cently has been reported in a family affected with a pul-
verulent cataract, a clinically distinct phenotype (Ste-
phan et al. 1999). This further supports the newly
documented role of CRYGD in cataract formation.
The role ofCRYGC in the process of lens opacification
is documented here for the first time. The 225ArC mu-
tation may disturb the protein function and/or the pro-
tein’s interaction with neighboring proteins, in part be-
cause of the amino acid change. Proline, the mutant
amino acid, is established as a potent breaker of b-sheet
structures in soluble proteins (Wood et al. 1995; Li et
al. 1996). This amino acid change to proline could de-
stabilize the b-strand, which may impair the folding of
the protein and lead to lens opacification.
The T5P mutation ofCRYGC represents the true
Coppock-like–cataract mutation and the first associa-
tion of this gene with human cataracts. This finding sup-
ports our suggestion that previously reported sequence
changes in the CRYGE promoter region are not causally
related to a cataract phenotype. The R58H mutation
supports the previously proposed role of CRYGD in the
lens-opacification process. Further study of the related
proteins should contribute to a better understanding of
the process of cataract formation.
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